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RESEARCH ARTICLE
iTRAQ proteomics analysis reveals that PI3k is highly
associated with bupivacaine-induced neurotoxicity
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Bupivacaine, a commonly used local anesthetic, has potential neurotoxicity through diverse
signaling pathways. However, the key mechanism of bupivacaine-induced neurotoxicity re-
mains unclear. Cultured human SH-SY5Y neuroblastoma cells were treated (bupivacaine) or
untreated (control) with bupivacaine for 24 h. Compared to the control group, bupivacaine
signiﬁcantly increased cyto-inhibition, cellular reactive oxygen species, DNA damage, mito-
chondrial injury, apoptosis (increased TUNEL-positive cells, cleaved caspase 3, and Bcl-2/Bax),
and activated autophagy (enhanced LC3II/LC3I ratio). To explore changes in protein expression
and intercommunication among the pathways involved in bupivacaine-induced neurotoxicity,
an 8-plex iTRAQ proteomic technique and bioinformatics analysis were performed. Compared
to the control group, 241 differentially expressed proteins were identiﬁed, of which, 145 were
up-regulated and 96 were down-regulated. Bioinformatics analysis of the cross-talk between
the signiﬁcant proteins with altered expression in bupivacaine-induced neurotoxicity indicated
that phosphatidyl-3-kinase (PI3K) was the most frequently targeted protein in each of the
interactions. We further conﬁrmed these results by determining the downstream targets of
the identiﬁed signaling pathways (PI3K, Akt, FoxO1, Erk, and JNK). In conclusion, our study
demonstrated that PI3K may play a central role in contacting and regulating the signaling
pathways that contribute to bupivacaine-induced neurotoxicity.
Keywords:
Bupivacaine / Itraq / Local anesthetic / Neurotoxicity / PI3K
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1 Introduction
Local anesthetics (LAs) are necessary for epidural anesthesia,
spinal anesthesia, peripheral nerve blocks, and pain manage-
Correspondence: Shiyuan Xu, Department of Anesthesiology,
Zhujiang Hospital, Southern Medical University, 253 Industrial
Road, Guangzhou City, Guangdong Province, ChinaQ2
E-mail: xushiyuan355@163.com
Abbreviations: DHE, dihydroethidium; iTRAQ, Isobaric tagging
for relative and absolute protein quantiﬁcation; LA, local anes-
thetics; LDH, Lactate Dehydrogenase; MAPK, mitogen-activated
protein kinase; mTOR, Mammalian target of rapamyc; NAC, N-
acetyl cysteine; PI3K, Phosphoinositide3-kinases; ROS, reactive
oxygen species
ment, but the continuous application of a high concentration
of LA or a long-term exposure to LA can cause neurotoxicity
[1–3]. Although the incidence of neurotoxicity due to the ap-
plication of clinical concentrations of LAs is rare, it is a severe
problem once it occurs. Epidemiology surveys suggest that
complications, such as transient neurologic syndrome (TNS),
may occur in more than 30% of patients who receive spinal
anesthetics. Serious complications, such as cauda equina syn-
drome, affect approximately 1 in 8000 patients [4–7].
Bupivacaine, an amide-type local anesthetic, is one of the
most widely used local anesthetics in clinics. Studies in
∗Additional corresponding author: Dr. Zhengyuan Xia
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animal and cellular models have shown that bupivacaine
can be neurotoxic when applied to neural tissues at clini-
cal concentrations [1, 8, 9]. Multiple factors contribute to the
neurotoxicity of bupivacaine. The generation of excess reac-
tive oxygen species (ROS) [10], which are normal by-products
of cellular metabolism, can destabilize intracellular calcium
homeostasis [11], activate MAPKs [12] and may be involved
in the pathogenesis of bupivacaine-induced apoptosis. Lirk
et al. demonstrated that bupivacaine-induced apoptosis in-
volves the generation of ROS in Schwann cells and activates
p38-MAPK in dorsal root ganglion (DRG) neurons. A recent
study showed that ROS over-production, concomitant with
the inhibition of the Akt/mTOR/p70S6K signaling pathway,
contributed to Streptococcus pneumoniae-induced autophagy
(a programmed cell death pathway) in A549 Cells [13]. We
recently demonstrated that bupivacaine-induced ROS gen-
eration was a mechanism by which cellular toxicity was pro-
duced [14]. Furthermore, impaired autophagosome clearance
contributes to bupivacaine-inducedmyotoxicity inmousemy-
oblasts [9]. All of these studies indicate that bupivacaine may
induce neurotoxicity primarily through autophagy and apop-
tosis. It has been shown that there is a frequent interplay be-
tween autophagy and apoptosis [15]. However, to date, there
are no systematic studies regarding the potential interplay
between autophagy and apoptosis nor are there any studies
on the underlying mechanism governing this interplay in
bupivacaine-induced neurotoxicity.
In the present study, we examined bupivacaine-induced
neurotoxicity in vitro in SH-SY5Y cells, an undifferentiated
human neuroblastoma cell line [16,17]. We used isobaric tag-
ging for relative and absolute protein quantiﬁcation (iTRAQ)
[18–20], a powerful proteomics method developed to detect
the changes in protein expression in different biological sam-
ples, to explore the changes in protein expression and in-
tercommunication in bupivacaine-induced neurotoxicity re-
lated pathways. The signiﬁcant changes and connections
in signaling pathways identiﬁed by bioinformatics analysis
were tested/conﬁrmed in cell models of bupivacaine-induced
neurotoxicity.
2 Materials and methods
2.1 Reagents
Bupivacaine was purchased from Sigma, USA. DMEM-F12,
fetal calf serum and pancreatic enzyme (including or exclud-
ing) EDTA were purchased from Gibco, USA. SH-SY5Y cells
were obtained from the cell bank of the Chinese Academy of
Sciences (Shanghai, China).
2.2 Cell culture and treatment
SH-SY5Y, an undifferentiated human neuroblastoma cell
line, was grown in DMEM-F12 (Gibco, USA) supplemented
with 10% fetal bovine serum, penicillin (100U/mL) and strep-
tomycin (100 g/mL) in a humidiﬁed 5% CO2 atmosphere
incubator at 37C. The culture medium was renewed once a
day during cell growth. After seeding onto plates for 24 h,
cells were exposed to bupivacaine for 24 h.
2.3 Measurement of cell viability using
the CCK-8 assay
SH-SY5Y cells were seeded at a density of 1 × 104 cells per
well in a 96-well cell culture plate, and cell viability was deter-
mined with the Cell Counting Kit-8 (CCK8, Dojindo, Japan)
according to the manufacturer’s instructions. Brieﬂy, after
the cells were exposed to bupivacaine (0, 0.5, 1.0, 1.5, 2.0,
and 2.5 mM) for 24 h, CCK-8 (10 L/well) was added and
incubated for an additional 4 h at 37C, according to the in-
structions provided by manufacturer. The optical density of
the homogeneous purple solutions was measured at 450 nm
using a spectrophotometer. In parallel, cells were cultured
in DMEM-F12 medium under the same conditions. Each
experiment was performed in triplicate, and the viability of
the control group without bupivacaine treatment was set as
100%; the other groupswerenormalized to the corresponding
control values.
2.4 Hoechst 33258 ﬂuorescence detection
Cells were seeded onto 24-well plates at 1 × 105 cells/well
in 500 L culture medium and assigned to two groups: (i)
untreated control (Con) and (ii) cells treated with 1.5 mM
bupivacaine for 24 h (Bup). After incubation, ﬂuorescent mi-
croscopy analysis was performed using Hoechst 33258 stain-
ing (Sigma, USA) to detect cell apoptosis, a process during
which the dye enters the cell and changes in the target cell
nucleus and DNA damage occur. The images were observed
and captured with a ﬂuorescent microscope (BX41System
microscope; Olympus, DP72 digital camera) at the 340 nm
excitation wavelength (UV-light) as previously described [21].
2.5 Determination of Cellular Injury
Cells were seeded onto 6-well plates at 5 × 105 cells/well in
2 mL culture medium. Brieﬂy, after the cells were exposed
to bupivacaine (0, 0.5, 1.0, 1.5, 2.0, and 2.5 mM) for 24 h,
the lactate dehydrogenase (LDH) content was measured with
an LDH Cytotoxicity Assay Kit (Roche, Indianapolis, USA) as
described [22].
Cells were seeded onto 24-well plates at 1 × 105 cells/well
in 500 L culture medium and assigned to two groups: (i)
untreated control (Con) and (ii) cells treated with 1.5 mM
bupivacaine for 24 h (Bup). Cell apoptosis was detected by
double immunoﬂuorescence staining of TUNEL using the In
Situ Cell Death Detection Kit (Roche, Indianapolis, USA) as
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
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previously described [22]. Mitochondrial membrane potential
(MMP) loss was measured using a JC-1 mitochondrial mem-
brane potential assay kit (Cayman chemical) as described
[23]. The images were observed and captured with a ﬂuores-
cencemicroscope (BX41Systemmicroscope; Olympus, DP72
digital camera).
2.6 Comet assay
A single-cell gel electrophoresis assay (comet assay) was
applied to measure DNA damage including double-strand
breaks, single strand breaks, alkali labile sites, and oxidative
DNA base damage in individual cells. The SH-SY5Y cells (2×
105 cells) were plated in 6-well plates, and the extent of DNA
damage was measured using a kit (Trevigen’s Comet Assay R©
Kit), based on the manufacturer’s instructions. The images
were observed and captured with a ﬂuorescence microscope
(BX41System microscope; Olympus, DP72 digital camera) at
200x
magniﬁcation. A minimum of 50 randomly selected cells
(from each of the two replicate slides) were analyzed with
the Comet Assay Software Project (CASP-6.0, University of
Wroclaw, Poland).
2.7 Measurement of Cellular ROS in Cultured
SH-SY5Y cells
Cells were seeded onto 6-well plates at 5 × 105 cells/well in
2 mL culture medium. Superoxide generation in SH-SY5Y
cells was estimated by DHE staining as previously described
[22]. Brieﬂy, cells were loaded with DHE at a concentration
of 10 M for 30 min at 37°C. The images were observed
and captured under a ﬂuorescence microscope (BX41System
microscope; Olympus, DP72 digital camera). The DHE ﬂu-
orescence of DHE-labeled positive nuclei were calculated in
each of ﬁve randomly selected ﬁelds and were expressed as a
percentage of the DHE-stained positive nuclei compared with
the controls by a quantitative morphometric method.
2.8 Western blotting
Cells were seeded onto 6-well plates at 5 × 105 cells/well in
500 L culture medium and assigned to two groups: (i) un-
treated control (Con) and (ii) cells treatedwith 1.5mMbupiva-
caine for 24 h (Bup). After treatment, cells were lysed in lysis
buffer to extract the proteins. After centrifugation, the protein
was collected, and the protein concentration was determined
by the Bradford method for Western blotting. Equal amounts
of protein extracts were separated by 10% SDS-PAGE and
transferred to PVDF membranes (Immobilon-P, Millipore,
Bedford,MA,USA). The blots were blockedwith 5%milk and
incubated overnight at 4C with antibodies against caspase-3
rabbit, 1:1000; Cell Signaling cleaved-caspase3 rabbit, 1:1000;
Cell Signaling), Bax (rabbit, 1:1000; Cell Signaling), bcl-2 (rab-
bit, 1:1000; Cell Signaling), LC3-I/II (rabbit, 1:1000; Cell Sig-
naling), -tubulin (rabbit, 1:3000; Cell Signaling), PI3K, Akt,
p-Akt, FoxO1, p-FoxO1, JNK, P-JNK ERK and p-ERK (rab-
bit, 1:1000; Cell Signaling). These blots were further incu-
bated withHRP-conjugated secondary antibody, developed in
ECL solution, and exposed onto hyperﬁlm (Amersham Bio-
sciences) for 1–10 min. The intensity of the selected bands
was captured and analyzed using Image J software (NIH).
2.9 iTRAQ
2.9.1 Protein preparation
The SH-SY5Y cells exposed (as experimental group) or not
exposed (as control group) to 1.5mMbupivacaine were resus-
pended in lysis buffer (7 M urea, 2 M thiourea, 4c/o CHAPS,
40mMTris-HCl, pH 8.5, 1mMPMSF, and 2mMEDTA) and
sonicated on ice. Three biological replicates were performed
for each group. The control group samples were named C1,
C2, and C3. The experimental group samples were named
B1, B2, and B3. The proteins were reduced with 10 mM DTT
(ﬁnal concentration) at 56C for 1 h and then alkylated by
55 mM IAM (ﬁnal concentration) in the darkroom for 1 h.
After centrifuging at 30 000 × g at 4C, an aliquot of the su-
pernatant was used to determine the protein concentration
by the Bradford method.
2.9.2 iTRAQ labeling and SCX fractionation
Protein (100 g) was removed from each sample solution,
and then the protein was digested with Trypsin Gold
(Promega, Madison, WI, USA) with a ratio of protein: trypsin
= 30 : 1 at 37C for 16 h. Peptides were reconstituted in 0.5
M TEAB and processed according to the manufacturer’s pro-
tocol for 8-plex iTRAQ reagent (Applied Biosystems). Brieﬂy,
one unit of iTRAQ reagent was thawed and reconstituted in
24 L isopropanol. Samples were labeled with the iTRAQ
tags as follows: control groups C1, C2, and C3 (tag 116,
117, 115, respectively) and experimental groups B1, B2, and
B3 (tag 118, 119, and 121, respectively). The peptides were
labeled with isobaric tags and incubated at room temperature
for 2 h. The iTRAQ-labeled peptide mixtures were reconsti-
tuted with 4mL buffer A (25mMNaH2PO4 in 25%ACN, pH
2.7) and loaded onto a 4.6 × 250 mm Ultremex SCX column
containing 5-m particles (Phenomenex). The peptides
were eluted at a ﬂow rate of 1 mL/min with a gradient of
buffer A for 10 min, 5–60% buffer B (25 mM NaH2PO4,
1 M KCl in 25% ACN, pH 2.7) for 27 min, and 60–100%
buffer B for 1 min. The system was then maintained at 100%
buffer B for 1 min before equilibrating with buffer A for
10 min prior to the next injection. Elution was monitored
by measuring the absorbance at 214 nm, and fractions were
collected every 1 min. The eluted peptides were pooled into
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
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20 fractions, desalted with a Strata X C18 column (Phe-
nomenex) and vacuum-dried.
2.9.3 LC-ESI-MS/MS analysis based on Q-EXACTIVE
Each fractionwas resuspended inbufferC (2%ACN, 0.1%FA)
and centrifuged at 20 000 × g for 10 min; the ﬁnal concen-
tration of peptide was approximately 0.5 g/L on average.
We loaded 10 L supernatant onto a LC-20AD nano HPLC
(Shimadzu, Kyoto, Japan) by the auto sampler onto a 2 cm
C18 trap column. The samples were loaded at 8 L/min for
4 min. Then, the gradient was run at 300 nL/min starting
from 2 to 35% of buffer D (98% ACN, 0.1% FA), followed by
a 2 min linear gradient to 80% buffer D, maintenance at 80%
buffer D for 4 min, and ﬁnally a return to 5% in 1 min.
The peptides were subjected to nano-electrospray ioniza-
tion followed by tandem mass spectrometry (MS/MS) in a
Q-EXACTIVE (Thermo Fisher Scientiﬁc, San Jose, CA) cou-
pled online to the HPLC. Intact peptides were detected in
the Orbitrap at a resolution of 70 000. A data-dependent
procedure that alternated between one MS scan followed by
15 MS/MS scans was applied for the 15 most abundant pre-
cursor ions above a threshold ion count of 20 000 in the MS
survey scan with a following Dynamic Exclusion duration of
15 s. The electrospray voltage applied was 1.6 kV. The AGC
target for fullMSwas 3e6 and forMS2was 1e5. ForMS scans,
the m/z scan range was from 350 to 2000 Da. For MS2 scans,
the m/z scan range was 100–1800.
2.9.4 Data analysis
Raw data ﬁles acquired from theOrbitrap were converted into
MGF ﬁles using Proteome Discoverer 1.2 (PD 1.2, Thermo;
5600 msconverter), and the MGF ﬁles were then searched.
Protein identiﬁcation was performed by using the Mascot
search engine (Matrix Science, London, UK; version 2.3.02)
against the UniProt knowledge base containing 83 425 pro-
tein sequences (http://www.uniprot.org/uniprot/?query =
taxonomy:9606). For protein identiﬁcation, a mass tolerance
of 30 ppm was permitted for intact peptide masses and 0.05
Da for fragmented ions, with allowance for one missed cleav-
age in the trypsin digests. Gln→ pyro-Glu (N-term Q), oxida-
tion (M), and deamidation (NQ) were tested as potential vari-
able modiﬁcations, and carbamidomethyl (C), iTRAQ8plex
(N-term), and iTRAQ 8plex (K) were tested as ﬁxed modi-
ﬁcations. The charge states of peptides were set to +2 and
+3. Speciﬁcally, an automatic decoy database search was per-
formed in Mascot by choosing the decoy checkbox in which a
random sequence of the database is generated and tested for
raw spectra as well as the real database; each conﬁdent pro-
tein identiﬁcation involves at least one unique peptide. For
protein quantitation, it was required that a protein contain at
least two unique spectra. The quantitative protein ratios were
weighed and normalized by the median ratio in Mascot. We
only used ratios with p-values < 0.05; only fold changes >1.2
were considered signiﬁcant.
2.9.5 Bioinformatics analysis of proteomics data
Identiﬁed proteins were classiﬁed according to annotations
from the UniProt knowledge base (Swiss-Prot/TrEMBL,
http://www.uniprot.org). Based on these proteins, an inter-
action network was constructed using the Web Search Tool
for the Retrieval of Interacting Genes/Proteins (STRING,
http://www.string-db.org), including both validated physical
protein-protein interaction and putative interaction inferred
from co-expression, gene fusion, and text mining, etc. Next,
KEGG pathway enrichment analysis was performedwith pro-
teins in this network. The network was then imported into
Cytoscape2.3.2 (www.cytoscape.org) [24] for topology analy-
sis. The number of Directed Edges indicated the frequency
of cross-talk in the network.
2.10 Statistical analysis
Results are expressed as themean ± standard deviation (SD).
Student’s t-test or one way ANOVA with repeated measures
was used for statistical analyses (Graph Pad Prism, USA) of
the data, where applicable. Unless otherwise speciﬁed, statis-
tical analysis of the quantitative multiple group comparisons
was assessed with ANOVA followed by Duncan’s test (two
sided). All tests were considered to be statistically signiﬁcant
when P < 0.05.
3 Results
3.1 Bupivacaine-induced cell injury in SH-SY5Y cells
in a dose-dependent manner
After the cells were exposed to bupivacaine (0, 0.5, 1.0, 1.5, 2.0,
and 2.5 mM) for 24 h, SH-SY5Y cell viability was determined
with the Cell Counting Kit-8 and the lactate dehydrogenase
(LDH) content was measured with an LDH Cytotoxicity As-
say Kit. As shown in Fig. 1A, bupivacaine treatment (0, 0.5,
1.0, 1.5, 2.0, and 2.5 mM) for 24 h decreased cell viability in a
dose-dependent manner ranging from 0% to 92.73±12.18%,
and the IC50 of bupivacaine was 1.5 mM (Fig. 1A). Bupi-
vacaine exposure (1.5, 2.0, and 2.5 mM) progressively and
signiﬁcantly increased cell injury, which manifested as el-
evated LDH release (P < 0.05 versus 0 mM bupivacaine;
Fig. 1B). Therefore, we selected 1.5 mM bupivacaine for use
in our cell injury model in the ensuing studies [1, 2].
3.2 Bupivacaine-induced apoptosis and DNA
damage in SH-SY5Y cells
Cell apoptosis in SH-SY5Y cells was determined by Hoechst
33258 and TUNEL staining. After incubation with 1.5 mM
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
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Figure 1. Different concentrations of
bupivacaine-induced SH-SY5Y cell in-
jury, apoptosis and DNA damage. (A) The cell
inhibition ratio was tested by CCK-8 assay
after exposure to 0, 0.5, 1.0, 1.5, 2.0, or 2.5 mM
bupivacaine for 24 h (IC501.5 mM.). (B). Cell
death was assessed by lactate dehydrogenase
(LDH) release after exposure to (0, 0.5, 1.0,
1.5, 2.0, and 2.5 mM) bupivacaine for 24 h.
(C, D) Nuclear condensation was determined
by Hoechst 33258 staining after treating
cells with 1.5 mM bupivacaine for 24 h. The
arrows indicate condensed and coalesced
nuclei with a brighter blue ﬂuorescence
(100 × magniﬁcation). (E, F) Cell apoptosis
was detected by TUNEL staining after cells
were exposed to 1.5 mM bupivacaine for 24
h. (G,H) An alkaline comet assay was used to
test 1.5 mM bupivacaine-induced cell DNA
damage. (H) The graph showed the analyzed
results of comet assay-related indicators.
Data are the mean ± SD of three independent
experiments performed in triplicate**, ##,
&& = P < 0.01, versus the C group.
bupivacaine for 24 h, bupivacaine signiﬁcantly increased cell
apoptosis, as evidenced by the elevated number of condensed
and coalesced nuclei and increased TUNEL positive cells in
bupivacaine treated cells compared with the control group
(Fig. 1C–F). As shown in Fig. 1G, DNA damage was deter-
mined by alkaline comet assay and showed that the nucleus of
cells in the control group were nearly round. In bupivacaine-
treated cells, DNA fragment migration formed a comet with
a small head and a large tail. These characteristics of DNA
damage were further conﬁrmed by the analyzed curves [the
non-DNA damage cells showed a single peak (head DNA)
while the DNA damage cells had double peaks (head DNA
and tail DNA)]. In cells of the control group, a single peak
was observed with a higher head DNA% (P < 0.05 versus
bupivacaine group), while in the bupivacaine-treated cells,
tail DNA % and olive tail movement were increased and as-
sociated with decreased head DNA % (Fig. 1H; P < 0.01).
These data indicated that (1.5 mM) bupivacaine signiﬁcantly
caused DNA damage in SH-SY5Y cells.
3.3 Bupivacaine induced oxidative stress and
mitochondrial damage in SH-SY5Y cells
To demonstrate the production of ROS after the cells were
exposed to bupivacaine, we used DHE(dihydroethidium) as a
probe to measure ROS. Bupivacaine treatment signiﬁcantly
increased cellular ROS production, as evidenced by the en-
hanced DHE red ﬂuorescence (Fig. 2A and B). This was asso-
ciated with MMP shown as a reduced red/green ﬂuorescence
ratio in JC-1 staining. This is a reﬂection of a reduction in
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
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Figure 2. Bupivacaine induced oxidative stress
and mitochondrial damage in SH-SY5Y cells.
(A, B) Cellular ROS production was assessed
by dihydroethidium (DHE) staining in SH-
SY5Y cells exposed to 1.5 mM bupivacaine.
Mitochondrial membrane permeability (MMP)
loss was tested by JC-1 staining. (D) Panel-
C: control group cells showing that most cells
had strong J-aggregation (red). Panel-B upper:
1.5 mM bupivacaine treated cells showing that
the majority of cells stained green due to low
m. (C) The expression of apoptosis- and
autophagy-related proteins was increased af-
ter SH-SY5Y cells were stimulated with 1.5 mM
bupivacaine for 24 h. Bupivacaine downregu-
lated the expression of total caspase-3 (G) and
the Bcl-2/Bax ratio (H), while increasing the
level of cleaved/active caspase-3 (F) and the
ratio of LC3Ⅱ/Ⅰ (I). Densitometry analysis was
performed via normalization to -tubulin. Data
are the mean ± SD of three independent ex-
periments performed in triplicate (***P < 0.001,
#P < 0.05, **P < 0.01 versus C group).
mitochondrial transmembrane potential and mitochondrial
damage (Fig. 2C and D; P < 0.001 versus C group).
3.4 Bupivacaine activated apoptosis- and
autophagy-related proteins in SH-SY5Y cells
After stimulation with (1.5 mM) bupivacaine for 24 h, in
bupivacaine-treated cells, the apoptosis-related protein ex-
pression of total caspase-3 (Fig. 2E and G) and the Bcl-2/Bax
ratio (Fig. 2E and H) were down-regulated, while the level
of cleaved/active caspase 3 (Fig. 2E and F) were increased (P
< 0.05 versus the C group). We next examine the changes
in LC3 conversion, a marker for autophagosome forma-
tion according to the guidelines for monitoring autophagy.
The ratio of LC3 II/I (Fig. 2E and I) was signiﬁcantly in-
creased (P< 0.05 versus the C group). These results indicated
that bupivacaine may simultaneously activate apoptosis and
autophagy.
3.5 iTRAQ proteomics analysis
A quantitative proteome analysis based on iTRAQ labeling
was performed to explore changes in protein expression
and intercommunications among pathways related to
bupivacaine-induced neurotoxicity. To reduce the probability
of false peptide identiﬁcation, only peptides at a 95% conﬁ-
dence interval by aMASCOT probability analysis greater than
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Figure 3. The total number of spectra, peptides, and identiﬁed proteins (A) are shown. Of the total identiﬁed proteins, 241 proteins were
signiﬁcantly different between the (1.5 mM) bupivacaine and C groups and included 145 upregulated and 96 downregulated proteins (B).
Classiﬁcation of the identiﬁed signiﬁcant proteins. The biological processes (BPs), cellular components (CCs), and molecular functions
(MFs) of the identiﬁed signiﬁcant proteins were classiﬁed by the GO database (C).
“identity” were counted as identiﬁed. Each conﬁdent protein
identiﬁcation involved at least one unique peptide. For
protein quantitation, it was required that a protein contain at
least two unique spectra. The quantitative protein ratios were
weighed and normalized by the median ratio in Mascot. We
only used ratios with p-values <0.05, and only fold changes
of >1.2 were considered as signiﬁcant. A total of 415 324
spectra (Fig. 3A) were obtained from the iTRAQ -LC-MS/MS
proteomic analysis. After data ﬁltering to eliminate low-
scoring spectra, a total of 61 746 unique spectra (Fig. 3A) were
found to meet the strict conﬁdence. A total of 4139 proteins
(Fig. 3A) were identiﬁed and quantiﬁed at more than a 95%
CI, and proteins with no less than two unique peptides were
considered to be a positive identiﬁcation. Accordingly, 145
and 96 proteins were signiﬁcantly up- and down-regulated,
respectively, in the bupivacaine-treated group (Fig. 3B).
To expand on the molecular characterization of these
identiﬁed signiﬁcant proteins, the Uniport databases were
searched to provide relevant information about their biologi-
cal processes, cellular components, and molecular functions
(Fig. 3C).
Furthermore, the cross-talk between these key networks
involved many signiﬁcant proteins and cell death path-
ways (apoptosis, mTOR, MAPK, PI3K, and insulin sig-
naling). Interestingly, in accordance with cross-talk bioin-
formatics analysis, PI3K (PIK3CB and PIK3R2) was the
most frequently targeted protein in each of the interactions
(Fig. 4A and B).
3.6 Validation of the expression of key proteins
in the PI3K/Akt/FoxO1 and MAPK pathways
by western blotting
To conﬁrm the results from our iTRAQ analysis, which
showed a central role for PI3K in bupivacaine-induced neu-
rotoxicity, we determined the expression of the key pro-
teins in the PI3K/Akt/FoxO1 and MAPKs pathways. As
shown in Fig. 5A and B, in SH-SY5Y cells, after bupi-
vacaine stimulation, PI3K protein expression, Akt phos-
phorylation/activation (p-Akt), and FoxO1 phosphorylation/
activation (p-FoxO1) were signiﬁcantly reduced (P < 0.01
versus control). Moreover, the activation of Erk (p-Erk) was
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Figure 4. Subnetwork diagram of the PI3K-
centered protein interaction map. Protein-
protein interaction network analysis using
STRING and the free software Cytoscape2.3.2
(www.cytoscape.org) revealed that the signif-
icant proteins from the bupivacaine-induced
neurotoxicity-related signaling pathways (such as
apoptosis, autophagy, MAPK, and mTOR) were
highly associated withmolecular PI3K. Additional
interacting proteins are linked by grey and red
lines (A). The number of Directed Edges indicated
the frequency of cross-talk in the network (B). The
isoforms of PI3K (PIK3CB and PIK3R2) had the
most directed edges.
signiﬁcantly reduced, while the activation of JNK (p-JNK) was
signiﬁcantly increased after bupivacaine exposure (P < 0.05
versus the control; Fig. 5C–F).
4 Discussion
In this study, we showed that bupivacaine induced neurotoxi-
city by inducing cellular ROS overproduction, mitochondrial
damage, DNA damage, neuronal apoptosis, and autophagy.
Further, by using iTRAQ and bioinformatics analyses, we
identiﬁed signiﬁcant proteins in cell death related pathways
for the ﬁrst time in bupivacaine-treated cells (apoptosis,
mTOR, MAPK, PI3K, and insulin) that were highly interac-
tive and converged on the inactivation of PI3K, indicating that
PI3K plays a central role in contacting and regulating differ-
ent pathways related to bupivacaine–induced neurotoxicity.
Bupivacaine, an amide type local anesthetic, is one of
the most widely used local anesthetics in clinics. Studies in
animal and cellular models have proven that bupivacaine
can be neurotoxic when applied to neural tissues at clinical
concentrations [1, 8] [9]. Multiple factors contribute to the
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Figure 5. The effect of (1.5 mM) bupivacaine
on the protein expression of PI3K/Akt/FoxO1
and MAPK pathway proteins (Erk and Jnk)
were conﬁrmed by Western blot. Data are the
mean ± SD of three independent experiments
performed in triplicate*, #, & = P < 0.05, **P <
0.01 versus C group).
neurotoxicity of bupivacaine, including the overproduction
of ROS and the impairment of autophagy, which all lead
to neuronal cell apoptosis. In a Schwann cell model, bupi-
vacaine induction increased ROS production and activated
apoptosis-related proteins, resulting in cell apoptosis. These
toxic effects of bupivacaine were attenuated by anti-oxidant
treatment, indicating that ROS overproduction plays an
important role in bupivacaine neurotoxicity. On the other
hand, a recent study by Li et al. showed that bupivacaine
induced toxicity by impairing autophagosome clearance in
C2C12 cells, which was reversed by rapamycin (autophagy
activator), implicating autophagy in bupivacaine-induced
toxicity [9]. In our current study, the administration of
bupivacaine in SH-SY5Y cells (human neuroblastoma cell
line, were the established in vitro models that have been
widely used for investigating the neurotoxicity of local anes-
thetics and other drugs-induced neurotoxicity, metabolism
and signaling transduction pathways) induced the excess
generation of ROS, which was associated with the activation
of autophagy (manifested as an enhanced expression of LC3,
an autophagosome marker) and apoptosis (enhanced ex-
pression of apoptosis related proteins: cleaved caspase 3 and
the Bax/Bcl-2 ratio; Fig. 2). These results provide additional
evidence for the involvement of ROS overproduction, the
activation of autophagy, and the induction of apoptosis in
the pathogenesis of bupivacaine-induced neurotoxicity.
Different signaling pathways have been proposed to un-
derlie the neurotoxicity of bupivacaine, such as p38-MAPK,
Erk, and JNK [12,24–26]. Studies showed that cross-talk may
exist among p-38MAPK, Erk, and JNK [27] and that signaling
pathways related to apoptosis may also be involved. However,
to date, there are no studies that have investigated the inter-
action of these pathways in bupivacaine-induced neurotoxi-
city. In the current study, by employing iTRAQ proteomic
and bioinformatics analyses, we showed, for the ﬁrst time
that the phosphoinositide 3 kinase (PI3K) pathway plays a
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central role in contacting and regulating different pathways
in bupivacaine–induced neurotoxicity. Indeed, PI3K is con-
sidered one of the most important regulatory proteins, be-
cause it is involved in a series of different signaling pathways
and regulates primary cellular functions including immu-
nity, metabolism, and cardiac function [28, 29]. Recent stud-
ies showed that the inhibition of PI3K signaling enhanced
autophagy and thereby induced apoptosis [30–33]. Malcolm
Campbell showed that there was signiﬁcant cross-talk be-
tween the PI3K and MAPK pathways. Moreover, the inhibi-
tion ofmTORC1-mediated activation of theMAPKpathway is
PI3K-dependent [34]. PI3K also mediates the metabolic regu-
latory actions of insulin and insulin-induced gene expression
for various cellular differentiation and proliferation events,
which were mainly achieved through the activation of MAPK
and Erk [35]. These results provide evidence that PI3K acts
as a convergence point of signaling pathways in bupivacaine-
induced neurotoxicity. In the current study, our iTRAQ pro-
teomic analysis and bioinformatics analysis showed that, in
bupivacaine-treated SH-SY5Y cells, PI3Kwas down-regulated
and may be largely responsible for the alterations in signal-
ing pathways including apoptosis,MAPK,mTOR, autophagy,
andmetabolic signaling (Fig. 5A and Supporting Information
Table 1). Thus, an impairment in PI3K signaling may serve
as the major mechanism that underlies the pathogenesis of
bupivacaine-induced neurotoxicity. This concept was further
conﬁrmed in our study by determining the important down-
stream targets of the aforementioned signaling pathways,
such as Akt, FoxO1, Erk, and JNK. Thus, our current study
demonstrated that PI3K is central to signaling pathways that
are highly involved in the pathomechanism of bupivacaine-
induced neurotoxicity.
Interestingly, our iTRAQ proteomic analysis and bioinfor-
matics analysis results further showed that there are two iso-
forms of PI3K, namely PIK3R2 and PIK3CB, that are involved
in the PI3K-mediated neurotoxicity of bupivacaine (Fig. 5A).
PI3Ks are a family of three classes of lipid kinases, which, on
the basis of structural and biochemical characteristics, can
be divided into class I enzymes, which are receptor-regulated
PtdIns(4,5)P2 kinases; class II enzymes, which are PI3K–C2
kinases; and the class III enzyme,which is thePtdIns–speciﬁc
enzyme Vps34. [29, 36]. However, the contribution of differ-
ent PI3K isoforms to diverse organismal functions, as well as
diseases or pathological conditions remains unclear. In the
current study, in bupivacaine-treated SH-SY5Y cells, two iso-
forms (PIK3CB and PIK3R2) of PI3K were down-regulated.
Interaction knowledge fromSTRING (both physical and non-
physical) suggested that the two PI3K isoforms (PIK3CB and
PIK3R2)mayhave the potential to interactwith distinct genes,
indicating that different isoforms of PI3K may have differ-
ent effects in the PI3K regulatory network. However, further
studies and direct evidence are needed to investigate and dis-
tinguish the regulatory effects of different PI3K isoforms.
In conclusion, our current study demonstrated that bupiva-
caine exerts its neurotoxicity in SH-SY5Y cells by generating
excess ROS and activating autophagy, which were associated
with the modulation of signaling proteins that converge in
PI3K (i.e., PIK3CB and PIK3R2), eventually leading to neu-
ronal cell apoptosis. Thus, PI3K may serve as a novel target
in the treatment of local anesthetic neurotoxicity and specif-
ically bupivacaine-induced neurotoxicity. Effective strategies
that can up-regulate PI3K, especially PIK3CB and PIK3R2,
may attenuate bupivacaine-induced neurotoxicity in a clini-
cal setting, and this concept merits further investigation in in
vivo models of bupivacaine-induced neurotoxicity.
Signiﬁcance
In the current study, we ﬁrst showed that PI3Kmay play a cen-
tral role in contacting and regulating the signaling pathways
that contribute to bupivacaine-induced neurotoxicity. PI3K
may serve as a novel target in the treatment of local anes-
thetic neurotoxicity in general and bupivacaine neurotoxicity
in particular. Up-regulation of PI3K, especially PIK3CB and
PIK3R2, may attenuate bupivacaine-induced neurotoxicity in
a clinical setting.
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